Loading clinical trials...
Loading clinical trials...
This multicenter prospective cohort aims to evaluate whether combined changes in fecal calprotectin (FC) and fecal immunochemical test (FIT) at \*\*Week 2 and Week 4\*\* after initiating biologic ther...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Qilu Hospital of Shandong University
Collaborators
NCT07374471 · Ulcerative Colitis (UC)
NCT07271069 · Ulcerative Colitis (UC)
NCT07451912 · Acute Myeloid Leukemia (AML), CEBPA Mutation, and more
NCT06788275 · Percutaneous Coronary Intervention (PCI), Acute Myocardial Infarction, and more
NCT07245394 · Inflammatory Bowel Disease (IBD), Crohn Disease (CD), and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions